blockade with angiotensin converting enzyme (ACE) inhibitors or angiotensin II type 1 receptor blockers (ARBs) has turned out to be beneficial at all stages of this continuum. Several mechanisms ...
Routine use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is recommended in proteinuric nontransplant kidney disease patients, to reduce proteinuria and ...
To test the hypothesis that an angiotensin-receptor blocker (ARB), either alone or combined with an ACE inhibitor, is more effective than an ACE inhibitor alone in high-risk patients after MI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback